Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details)

v3.22.2.2
Net Loss per Share - Summary Of Potentially Dilutive Securities Excluded From Computation of Diluted Net Loss Per Share (Details) - shares
 3 Months Ended 9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Oct. 02, 2022
Oct. 03, 2021
Stock options outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 5,083,643 5,852,759 5,083,643 5,852,759
Restricted stock units and performance restricted stock units outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 5,933,914 117,611 5,933,914 117,611
Private Placement Warrants outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 6,000,000 0 0 0
Public Warrants outstanding        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 0 11,500,000 0 11,500,000
Employee stock purchase plan estimated shares        
Subsidiary Sale Of Stock [Line Items]        
Anti-dilutive securities (in shares) 380,847 0 380,847 0